SOD1 and amyotrophic lateral sclerosis: Given the potential benefits of early intervention in ALS, insights from ATLAS, combined with data from the VALOR study and its subsequent open-label extension, aim to provide clarity on the ideal timeframe for initiating treatment in cases of SOD1-ALS [144].